Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27.
Scapuloperoneal spinal muscular atrophy (SPSMA) and hereditary motor and sensory neuropathy type IIC (HMSN IIC, also known as HMSN2C or Charcot-Marie-Tooth disease type 2C (CMT2C)) are phenotypically heterogeneous disorders involving topographically distinct nerves and muscles. We originally described a large New England family of French-Canadian origin with SPSMA and an American family of English and Scottish descent with CMT2C. We mapped SPSMA and CMT2C risk loci to 12q24.1-q24.31 with an overlapping region between the two diseases. Further analysis reduced the CMT2C risk locus to a 4-Mb region. Here we report that SPSMA and CMT2C are allelic disorders caused by mutations in the gene encoding the transient receptor potential cation channel, subfamily V, member 4 (TRPV4). Functional analysis revealed that increased calcium channel activity is a distinct property of both SPSMA- and CMT2C-causing mutant proteins. Our findings link mutations in TRPV4 to altered calcium homeostasis and peripheral neuropathies, implying a pathogenic mechanism and possible options for therapy for these disorders.
肩腓型脊柱肌萎缩症(SPSMA)和遗传性运动感觉神经病 IIC 型(HMSN IIC,也称为 HMSN2C 或 Charcot-Marie-Tooth 病 2C 型(CMT2C))是表型异质性疾病,涉及到不同部位的神经和肌肉。我们最初描述了一个大型新英格兰法裔加拿大家族患有 SPSMA,以及一个具有英裔和苏格兰血统的美国家族患有 CMT2C。我们将 SPSMA 和 CMT2C 的风险基因座映射到 12q24.1-q24.31,两个疾病之间有重叠区域。进一步的分析将 CMT2C 的风险基因座缩小到 4-Mb 区域。在这里,我们报告 SPSMA 和 CMT2C 是由编码瞬时受体电位阳离子通道亚家族 V,成员 4(TRPV4)的基因突变引起的等位基因疾病。功能分析表明,钙通道活性的增加是 SPSMA 和 CMT2C 致病突变蛋白的一个独特特征。我们的发现将 TRPV4 的突变与钙稳态的改变和周围神经病变联系起来,暗示了这些疾病的发病机制和可能的治疗选择。
Nat Genet. 2009-12-27
Nat Genet. 2010-2
Neuromuscul Disord. 2015-6
Front Pediatr. 2024-3-18
Ann N Y Acad Sci. 2008-11
Biochemistry. 2008-2-26
J Biol Chem. 2008-3-7
J Biol Chem. 2007-12-14
Physiol Rev. 2007-1